Incannex Healthcare Inc. (IXHL) stock
IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.74−0.19 (-9.84%)
Close on Nov 17, 2026Market cap $21.83MP/E –Yield –
Incannex Healthcare ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Incannex Healthcare's ebitda for the twelve months ending Sep 30, 2026 was -$19.49M. For fiscal 2026 it was -$22.79M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$22.79M | – |
| FY2025 | Jun 30, 2025 | -$23.54M | – |
| FY2024 | Jun 30, 2024 | -$29.94M | – |
| FY2023 | Jun 30, 2023 | -$49.58M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -$3.43M | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$5.14M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$3.98M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$6.94M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$6.73M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$7.47M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$5.01M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$4.88M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$6.19M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$9.68M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$7.40M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$7.97M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$4.88M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$4.13M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$3.66M | – |
See a number that looks wrong?